US2021299080A1PendingUtilityA1

Method of treatment

Assignee: VANDA PHARMACEUTICALS INCPriority: Dec 15, 2015Filed: Apr 13, 2021Published: Sep 30, 2021
Est. expiryDec 15, 2035(~9.4 yrs left)· nominal 20-yr term from priority
A61K 31/343
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Embodiments of the invention relate generally to increasing adult height in individuals with no light perception (NLP).

Claims

exact text as granted — not AI-modified
1 . A method of increasing adult height in a blind person, the method comprising:
 entraining the person to a 24-hour sleep-wake cycle.   
     
     
         2 . The method of  claim 1 , wherein the person has not yet reached an age of average peak grown rate. 
     
     
         3 . The method of  claim 1 , wherein the person has no light perception. 
     
     
         4 . The method of  claim 1 , wherein the person is suffering from Non-24. 
     
     
         5 . The method of  claim 1 , wherein entraining the person comprises administering to the person an effective dose of tasimelteon or a pharmaceutically-acceptable salt thereof. 
     
     
         6 . The method of  claim 1 , wherein entraining the person comprises orally administering to the person 20 mg of tasimelteon once daily before a target bedtime.

Join the waitlist — get patent alerts

Track US2021299080A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.